.png){kind=icon}
.png){kind=icon}
Return
Use of mesoglycan in the acute phase of hemorrhoidal disease, The aCute HaemORrhoidal MEsoglycan Study (CHORMES): a double-blind, randomized controlled trial
.png){kind=icon}
PRE
AI
G
A
G
A
A
A
M
M
DOI：10.1016/j.surg.2026.110402.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Hemorrhoidal disease (HD) is a common condition with significant clinical and socioeconomic impact. Mesoglycan, with endothelial-protective, antithrombotic and profibrinolytic properties, has shown potential benefits in postoperative HD management. The CHORMES trial was designed to evaluate the efficacy and safety of mesoglycan in the acute phase of HD.
Journal
IF:
2.7
Papers:
1.2W
Citations:
2.2W
Organization
Cited Papers